Use of adjuvant intravenous bevacizumab for aggressive recurrent respiratory papillomatosis- A case report


Article PDF :

Veiw Full Text PDF

Article type :

Case Report

Author :

Deepa Shivnani

Volume :

9

Issue :

3

Abstract :

Recurrent Respiratory Papillomatosis (RRP) is a benign condition which needs frequent surgical interventions for debulking of papillomatosis lesions for securing the airway. There is no definitive treatment for the management of RRP so far. Bevacizumab either intralesional or systemic has emerged as a promising solution for RRP patients undergoing repeated surgeries. We are reporting a case of a 6-year-old child with juvenile onset RRP who was treated by surgical excision of lesion with adjuvant systemic bevacizumab therapy.

Keyword :

JORRP, Medical Treatment, Bevacizumab